iBio (IBIO) Cash from Investing Activities (2010 - 2026)

iBio (IBIO) has reported Cash from Investing Activities for 17 consecutive years, with -$3.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 22121.43% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at -$27.5 million (down 5080.47% YoY), while the FY2025 annual figure was $742000.0, down 18.1% from the prior year.
• Cash from Investing Activities declined to -$3.1 million in Q1 2026 per IBIO's latest filing, from -$3.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $8.2 million in Q1 2023 and bottomed at -$21.5 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$1.1 million across 5 years, with a median of $13500.0 in 2022.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 1494.0% — and 2025, when it sank 149050.0%.
• iBio's Cash from Investing Activities stood at -$1.3 million in 2022, then surged by 103.98% to $50000.0 in 2023, then plunged by 104.0% to -$2000.0 in 2024, then tumbled by 149050.0% to -$3.0 million in 2025, then fell by 4.29% to -$3.1 million in 2026.
• Business Quant data shows IBIO's Cash from Investing Activities at -$3.1 million in Q1 2026, -$3.0 million in Q4 2025, and -$21.5 million in Q3 2025.